|
|
|
| Skeletal muscle loss correlates toxic reaction and chemotherapy efficacy in patients with advanced lung cancer |
| 1 YAO Ke-qing, 1 CONG Ming-hua, 2 DAI Zhong, |
|
|
|
|
Abstract Objective To evaluate the correlation between the skeletal muscle loss with the toxicity and efficacy in advanced lung cancer patients. Methods 35 advanced lung cancer patients treated with platinum-based doublet chemotherapy were included in this study. Skeletal muscle mass was measured by the human body composition analyzer. And nutritional status of patients were assessed by the scored patient-generated subjective global assessment (PG-SGA). After 2 cycles chemotherapy, the change of nutritional status, incidence of complications, and prognosis were compared between the decrease group (skeletal muscle loss>2%) and the control group (skeletal muscle loss≤2%). Results Compared with before treatment, patients in the control group had significantly lower PG-SGA scores (5.55±4.01 vs 3.25±2.84, P<0.05) and significantly higher prealbumin levels [(23.62±5.53)g/L vs (27.45±5.26g/L, P<0.05] after 2 cycles of chemotherapy. Besides, we found that patients in the decrease group had significantly higher incidence of I degree anemia (35% vs 66%, P<0.05), II-III grade gastrointestinal reaction (35% vs 66%, P<0.05) and PD (5% vs 20%, P<0.05), and significantly lower incidence of PR (35% vs 13.3%, P<0.05) than in the control group. Conclusions The skeletal muscle loss>2% during chemotherapy could influence the incidence of side effects and efficacy, suggesting that it may serve as a predictor of side effects and prognosis of chemotherapy
|
|
|
|
|
|
| Cite this article: |
|
1 YAO Ke-qing,1 CONG Ming-hua,2 DAI Zhong. Skeletal muscle loss correlates toxic reaction and chemotherapy efficacy in patients with advanced lung cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2018, 5(1): 59-62.
|
|
|
|
| URL: |
| http://www.ejmnc.org/EN/ OR http://www.ejmnc.org/EN/Y2018/V5/I1/59 |
| [1] |
1YAO Ke-qing， 1WANG Su， 1CHEN Shuang， 1SUN Yan-teng， 1LIU Qing-yang， 1CHEN Tao，1LIU Xue-hui， 2CONG Ming-hua. Application of individualized nutrition diagnosis and intervention in patients with advanced cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 305-309. |
| [2] |
1LIU Yong-bo，2，3DENG Li， 1GUO Yi-hui，1LI Yan-ping. Atg13 gene overexpression induces chemotherapy resistance in triple-negative breast cancer cells[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 310-315. |
| [3] |
1，2GENG Bi-zhu, 1ZHENG Jin. Review of family nutrition support research during the intermission of chemotherapy[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 386-390. |
| [4] |
SHENG Xiang， LI Su-yi. Advances in research on intestinal microecology and clinical outcomes of tumors[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 178-182. |
| [5] |
ZIWAREGULI Nur, FANG Ruo-xin，LIAO Zheng-kai. The correlation between intestinal microecology and the efficacy of chemotherapy[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 161-166. |
| [6] |
JIANG Qian， WANG Yi， SUN Xiang. Clinical study of thalidomide plus Icotinib hydrochloride in the treatment of advanced pulmonary adenocarcinoma[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 216-220. |
|
|
|
|
